English | Spanish
ecancer
Supporting oncology professionals through education
Login Register

The content on this site is intended for healthcare professionals only

  • Home
  • News
  • Journal
  • Video
  • elearning
  • Events
  • Conferences
  • About us
Breast Prostate & urology Lung & pleura Colorectal & gastro Melanoma & skin Head & neck Ovary & gynaecology Bone Brain & nervous system Haematology oncology Hepatobiliary pancreatic Paediatric Neuroendocrine Sarcomas

News

  • Latest news
  • Sign up for news alerts
  • Submit your news

Explore

  • Bone
  • Brain & nervous system
  • Breast
  • Colorectal & gastro
  • Haematology oncology
  • Head & neck
  • Hepatobiliary pancreatic
  • Lung & pleura
  • Melanoma & skin
  • Neuroendocrine
  • Ovary & gynaecology
  • Paediatric
  • Prostate & urology
  • Sarcomas

Journal information

  • Journal home
  • Charges
  • Editorial board
  • Founding editors
  • Editor-in-chief
  • Contact us

Author information

  • Submit article
  • Author guidelines
  • Editorial policies
  • Copyright information
  • Why publish with us

Reviewer information

  • Reviewer guidelines

Memberships

Open Access Scholarly Publishers Association Crossref Healthcare Information For All Commitee On Publication Ethics

Videos

  • Recent videos
  • Sign up

Explore

  • Bone
  • Brain & nervous system
  • Breast
  • Colorectal & gastro
  • Haematology oncology
  • Head & neck
  • Hepatobiliary pancreatic
  • Lung & pleura
  • Melanoma & skin
  • Neuroendocrine
  • Ovary & gynaecology
  • Paediatric
  • Prostate & urology
  • Sarcomas

Conferences

  • Latest conferences
  • Sign up for latest coverage
  • Submit your event

About ecancer

  • About ecancer
  • Our founders
  • Funding statement
  • Contact us
  • Home
  • News
  • Journal
  • Video
  • elearning
  • Events
  • Conferences
  • About us
Breast Prostate & urology Lung & pleura Colorectal & gastro Melanoma & skin Head & neck Ovary & gynaecology
+ -
Bone Brain & nervous system Haematology oncology Hepatobiliary pancreatic Paediatric Neuroendocrine Sarcomas

ecancer and the City Cancer Challenge have formed an educational collaboration. Learners who are part of the City Cancer Challenge's project can access additional education provided by them.

Please login or register. Then you can use this button to confirm you are part of this project.
Register for free Already have an account? Login
Videos [1802]
News [2704]
Articles [198]
Editorials [1]
Conferences [135]
elearning [13]
Scientific breakthrough: We can now halve the price of costly cancer drug
Scientific breakthrough: We can now halve the price of costly cancer drug
Oleanolic acid restores drug sensitivity in sorafenib-resistant hepatocellular carcinoma: evidence from in vitro and in vivo studies
Oleanolic acid restores drug sensitivity in sorafenib-resistant hepatocellular carcinoma: evidence from in vitro...
New compound targets circadian clock machinery in cells to fight glioblastoma
New compound targets circadian clock machinery in cells to fight glioblastoma
Do bevacizumab’s ovarian cancer clinical trial results hold up in the real world?
Do bevacizumab’s ovarian cancer clinical trial results hold up in the real world?
ZW27941: A novel therapeutic strategy for acute myeloid leukaemia
ZW27941: A novel therapeutic strategy for acute myeloid leukaemia
A novel approach to liver cancer treatment: Unlocking the therapeutic potential of ADH4-driven retinoic acid metabolism
A novel approach to liver cancer treatment: Unlocking the therapeutic potential of ADH4-driven retinoic acid...
TAR-200 monotherapy achieves high disease-free survival of more than 80 percent in BCG-unresponsive, high-risk papillary NMIBC
TAR-200 monotherapy achieves high disease-free survival of more than 80 percent in BCG-unresponsive, high-risk...
AACR 2025: Oral investigational agent zoldonrasib elicits objective responses in patients with KRAS G12D-mutated lung cancer
AACR 2025: Oral investigational agent zoldonrasib elicits objective responses in patients with KRAS G12D-mutated...
Unlocking a new era in liver cancer treatment: The power of neddylation-targeted therapies
Unlocking a new era in liver cancer treatment: The power of neddylation-targeted therapies
Cancer research reveals how chemo impact cells at the molecular level
Cancer research reveals how chemo impact cells at the molecular level
<12345...271>

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation

  • Contact
  • Projects
  • Cookie Policy
  • Terms of Use
  • Desktop Site
  • Privacy Policy
© 2025 ecancer, all rights reserved
UK registered charity number: 1176307
Back to Top